Quest Partners LLC Increases Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Quest Partners LLC lifted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 4,087.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,263 shares of the company's stock after acquiring an additional 10,994 shares during the quarter. Quest Partners LLC owned 0.06% of Addus HomeCare worth $1,498,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Ellsworth Advisors LLC purchased a new stake in Addus HomeCare in the second quarter worth $598,000. Quadrature Capital Ltd bought a new position in shares of Addus HomeCare in the first quarter worth $1,557,000. SG Americas Securities LLC bought a new position in shares of Addus HomeCare in the second quarter worth $842,000. Dimensional Fund Advisors LP boosted its stake in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock valued at $82,930,000 after buying an additional 5,421 shares during the period. Finally, Point72 Asset Management L.P. boosted its stake in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after buying an additional 315,602 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently issued reports on ADUS. Macquarie reissued an "outperform" rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer lifted their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Monday, September 23rd. Royal Bank of Canada reissued an "outperform" rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They set an "overweight" rating and a $150.00 price target for the company. Finally, Stephens lifted their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $131.63.

Addus HomeCare Trading Up 0.7 %

Shares of ADUS stock traded up $0.79 during midday trading on Wednesday, reaching $120.99. 131,208 shares of the stock were exchanged, compared to its average volume of 131,569. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12. The company's 50 day moving average is $128.68 and its two-hundred day moving average is $122.89. The firm has a market cap of $2.19 billion, a PE ratio of 27.51, a price-to-earnings-growth ratio of 2.09 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the prior year, the business earned $1.03 EPS. The business's revenue for the quarter was up 7.1% on a year-over-year basis. As a group, equities analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company's stock, valued at approximately $961,687.35. This represents a 75.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the business's stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now owns 3,866 shares of the company's stock, valued at approximately $502,695.98. This represents a 11.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last ninety days. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.